Shakespeare Wealth Management’s Cantel Medical Corporation CMD Stock Holding History

Shakespeare Wealth Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,767	Closed	-$381K	–	76
2021 Q1	$381K	Hold	4,767	–	–	0.16%	51
2020 Q4	$376K	Hold	4,767	–	–	0.16%	50
2020 Q3	$209K	Hold	4,767	–	–	0.11%	66
2020 Q2	$211K	Buy	+4,767	New	+$178K	0.12%	62
2020 Q1	–	Sell	-4,767	Closed	-$338K	–	70
2019 Q4	$338K	Hold	4,767	–	–	0.18%	57
2019 Q3	$357K	Hold	4,767	–	–	0.21%	52
2019 Q2	$384K	Buy	+4,767	New	+$335K	0.25%	48

Shakespeare Wealth Management's CMD Position: Q2 2021 in Review

Shakespeare Wealth Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 4,767 shares — an estimated $381K sold.

Shakespeare Wealth Management first reported a position in CMD in Q2 2019 and held it in 7 quarters. The position peaked at $384K in Q2 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Shakespeare Wealth Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Shakespeare Wealth Management sold 4,767 Cantel Medical Corporation shares in Q2 2021, an estimated $381K.
Shakespeare Wealth Management first reported a position in Cantel Medical Corporation in Q2 2019 and held it in 7 quarters.
Shakespeare Wealth Management's Cantel Medical Corporation position peaked at $384K in Q2 2019.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Shakespeare Wealth Management's 13F filing for Q2 2021, filed 9 Aug 2021.